Vı́ctor Vargas - Concepedia

Author

Vı́ctor Vargas

Also Known As

Phillip Hylemon, V VARGAS, V Vargas, V. VARGAS, V. Vargas, V. Vargas Blasco, Vanessa B. Del Águila Vargas, Vargas, V, Vargas, Víctor, Veronica Margarita Vargas

288

Publications

18.7K

Citations

H-Index

134

Concepts

All Affiliations

Universitat Autònoma de Barcelona Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Vall d'Hebron Hospital Universitari Hospital Clínic de Barcelona Universitat de Barcelona

About

Vı́ctor Vargas is an author at Universitat Autònoma de Barcelona specializing in medicine, hepatology, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	42	61	10.2K
2	Health Sciences	15	16	2K
3	Public Health	6	6	698
4	Social Sciences	1	1	150
5	Biochemistry	1	1	43

Vı́ctor Vargas

126

Publications

18K

Citations

H-Index

Page 1

	Year	Citations
Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis Pau Sort, Miquel Navasa, Vicente Arroyo, New England Journal of Medicine	1999	1.6K
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Zobair M. Younossi, Vlad Ratziu, Rohit Loomba, The Lancet Interim AnalysisMetabolic Associated SteatohepatitisHepatologyPlacebo-controlled Phase 3Nonalcoholic Fatty Liver Disease	2019	1.2K
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis Frederik Nevens, Pietro Andreoné, G. Mazzella, New England Journal of Medicine	2016	1.1K
HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN L. Viladomiu, Antonio González, M Roget, The Lancet VaccinationVirus EpidemiologyHepatitis CViral HepatitisHepatitis	1989	900
Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease Yi Duan, Cristina Llorente, Sonja Lang, Nature DysbiosisHepatologyMedicineLiver PhysiologyLiver Disease	2019	778
Primary Prophylaxis of Spontaneous Bacterial Peritonitis Delays Hepatorenal Syndrome and Improves Survival in Cirrhosis Javier Fernández, Miquel Navasa, Ramón Planas, Gastroenterology HepatologyPrimary ProphylaxisLiver PhysiologyGastroenterologyPathology	2007	704
Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial Pere Ginès, Antoni Rimola, Ramón Planas, Hepatology	1990	633
Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis Àngels Ginès, Glòria Fernández‐Esparrach, Alberto Monescillo, Gastroenterology UrologyCirrhotic PatientsPharmacotherapyClinical ChemistryAcute Kidney Injury	1996	599
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology Jonel Trebicka, Javier Fernández, Mária Papp, Journal of Hepatology	2020	478
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide Salvatore Piano, Virendra Singh, Paolo Caraceni, Gastroenterology Bacterial InfectionsHepatologyCirrhosis WorldwideHealthcare-associated InfectionClinical Epidemiology	2018	473

Page 1